Title:Commercialization opportunity for an reactive scintillators with Mission Support and Test Services (MSTS).Background Information:A potent weapon for the destruction of cancerous tumors in the body has been photodynamic therapy using lasers where light can reach the cancer cells. One variant of these therapies uses a reagent that generates toxic levels of nitric oxide in targeted cells. Over the past several years, researchers have turned to X–rays as a method to deliver energy to deep tumors. MSTS has developed intellectual property for the combination of these two modalities with the potential to amplify the effects of X–ray radiation treatment and tumor destruction.Opportunity Description:MSTS possesses the intellectual property and know–how to develop reactive scintillators and is seeking partners in the development and commercialization effort of t
↧